abacavir 60 MG / dolutegravir 5 MG / 3TC 30 MG Tablet for Oral Suspension

RxCUI: 2598348
RxNorm name: abacavir 60 MG / dolutegravir 5 MG / 3TC 30 MG Tablet for Oral Suspension
Display name: abacavir 60 MG / dolutegravir 5 MG / 3TC 30 MG Tablet for Oral Suspension
Full name: abacavir 60 MG / dolutegravir 5 MG / 3TC 30 MG Tablet for Oral Suspension
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:51

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Triumeq	ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE	ViiV Healthcare Company	2997739a-aa91-42aa-a206-a70e2db7b84f	2024-07-08	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2598348

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
2997739a-aa91-42aa-a206-a70e2db7b84f	abacavir 60 MG / dolutegravir 5 MG / lamiVUDine 30 MG Tablet for Oral Suspension [PSN] · abacavir 60 MG / dolutegravir 5 MG / lamivudine 30 MG Tablet for Oral Suspension [SCD] · abacavir 60 MG (as abacavir sulfate 70.2 MG) / dolutegravir 5 MG (as dolutegravir sodium 5.26 MG) / lamivudine 30 MG Tablet for Oral Suspension [SY] · abacavir 60 MG / dolutegravir 5 MG / 3TC 30 MG Tablet for Oral Suspension [SY]	4	30	These highlights do not include all the information needed to use TRIUMEQ and TRIUMEQ PD safely and effectively. See full prescribing information for TRIUMEQ and TRIUMEQ PD. TRIUMEQ (abacavir, dolutegravir, and lamivudine) tablets, for oral use TRIUMEQ PD (abacavir, dolutegravir, and lamivudine) tablets for oral suspension Initial U.S. Approval: 2014	20240708